Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbon Capture Technologies (CCT) is an innovative biotechnology company specializing in the development of biological and enzymatic solutions for carbon sequestration and utilization. The company leverages advanced synthetic biology to engineer microorganisms and high-efficiency enzymes, such as carbonic anhydrase, to capture CO2 from industrial flue gases and atmospheric sources. Their technology platform aims to convert captured carbon into high-value biochemicals and sustainable materials, bridging the gap between industrial manufacturing and environmental stewardship. CCT's solutions are designed to be integrated into existing industrial infrastructures, providing a cost-effective and scalable pathway for hard-to-abate sectors to achieve net-zero goals. The company is currently focused on optimizing its microbial gas fermentation processes and expanding its portfolio of bio-based carbon utilization products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbon Capture Technologies.